Sec. 2. Optional coverage at no cost sharing of COVID–19 treatment and vaccines under Medicaid for uninsured individuals

828 words·~4 min read·/bill/116/s/4358/is/section-2

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Section 1902(a)(10) of the Social Security Act ( 42 U.S.C. 1396a(a)(10) ) is amended, in the matter following subparagraph (G), by striking and any visit described in section 1916(a)(2)(G) and inserting the following: , any COVID–19 vaccine that is administered during any such portion (and the administration of such vaccine), any item or service that is furnished during any such portion for the treatment of COVID–19, including drugs approved or authorized under section 505 or 564 of the Federal Food, Drug, and Cosmetic Act, or, in the case of an individual who is diagnosed with or presumed to have COVID–19, during the period such individual is infected (or presumed infected) with COVID–19, the treatment of a condition that may complicate the treatment of COVID–19, the treatment of a COVID–19-related condition that follows the treatment of, or hospitalization with, COVID–19, and any services described in section 1916(a)(2)(G) .

Subsection

(ss)of section 1902 of the Social Security Act ( 42 U.S.C. 1396a ) is amended to read as follows: For purposes of this section, the term uninsured individual means, notwithstanding any other provision of this title, any individual who is not covered by minimum essential coverage (as defined in section 5000A(f)(1) of the Internal Revenue Code of 1986). . The amendment made by paragraph

(1)shall take effect and apply as if included in the enactment of the Families First Coronavirus Response Act ( Public Law 116–127 ). For purposes of applying section 1903(v)(2)(A) of the Social Security Act ( 42 U.S.C. 1396b(v)(2)(A) ), the care and services described in such section shall include the following: In vitro diagnostic products (as defined in section 809.3(a) of title 21, Code of Federal Regulations), and the administration of such products. A COVID–19 vaccine (and the administration of such vaccine). Any item or service that is furnished for the treatment of COVID–19 or a condition that may complicate the treatment of COVID–19, the treatment of a COVID–19-related condition that follows the treatment of, or hospitalization with, COVID–19, and any services described in section 1916(a)(2)(G) of such Act ( 42 U.S.C. 1396o(a)(2)(G) ). For purposes of applying section 1903(v)(3) of the Social Security Act ( 42 U.S.C. 1396b(v)(3) ), the term emergency medical condition (as defined in such section 1903(v)(3)) shall include, with respect to an individual, any concern that the individual may have contracted COVID–19. Beginning on the date of enactment of this Act— the value of assistance or services provided to any person under a program with respect to which a coronavirus response law establishes or expands eligibility or benefits shall not be considered income or resources; and any medical coverage or services provided to an individual under subsection

(v)of section 1903 of the Social Security Act ( 42 U.S.C. 1396b ) shall be considered treatment for an emergency medical condition (as defined in subsection (v)(3) of such section) for any purpose under any Federal, State, or local law, including law relating to taxation, welfare, and public assistance programs; and a participating State or political subdivision of a State shall not decrease any assistance otherwise provided to an individual because of the receipt of benefits under the Social Security Act ( 42 U.S.C. 301 et seq.). In this section: The term coronavirus public health emergency means— an emergency involving Federal primary responsibility determined to exist by the President under section 501(b) of the Robert T. Stafford Disaster Relief and Emergency Assistance Act ( 42 U.S.C. 5191(b) ) with respect to COVID–19 or any other coronavirus with pandemic potential; an emergency declared by a Federal official with respect to coronavirus (as defined in section 506 of the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 ( Public Law 116–123 )); a national emergency declared by the President under the National Emergencies Act ( 50 U.S.C. 1601 et seq.) with respect to COVID–19 or any other coronavirus with pandemic potential; and a public health emergency declared by the Secretary of Health and Human Services pursuant to section 319 of the Public Health Service Act ( 42 U.S.C. 247(d) ) with respect to COVID–19 or any other coronavirus with pandemic potential. The term coronavirus response law means— the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 ( Public Law 116–123 ); the Families First Coronavirus Response Act ( Public Law 116–127 ); the Coronavirus Aid, Relief, and Economic Security Act ( Public Law 116–136 ); and any subsequent law that appropriates or otherwise makes available funds, establishes, amends, or expands a program, or authorizes activities or assistance for a purpose that is expressly related to responding to, or mitigating the effects of, a coronavirus public health emergency. Nothing in this section shall be construed to limit— the types of care and services that are necessary for the treatment of an emergency condition for purposes of section 1903(v) of the Social Security Act ( 42 U.S.C. 1396b(v) ); or the types of medical conditions that are emergency medical conditions for purposes of such section.

Connectionstraces to 10

Traces to 10 documents

U.S. Code